Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-01-10

Clinical Trial Update: Efficacy Study of Diazoxide Choline to Treat Hypertriglyceridemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating diazoxide choline for hypertriglyceridemia (a form of dyslipidemia) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • diazoxide choline (diazoxide choline)

Snippet

Sponsor: Essentialis, Inc. | Conditions: Hypertriglyceridemia, Dyslipidemia | Phase 2 | Status: COMPLETED